Improved clinical outcomes among persons with HIV who quit smoking

References

• Althoff, K. N. (2016). The shifting paradigm of care for adults living with HIV: Smoking cessation for longer life. Journal of Infectious Diseases, 214(11), 1618–1620.
   PubMed Web of Science ®Google Scholar
• Ashare, R. L., Thompson, M., Leone, F., Metzger, D., Gross, R., Mounzer, K., … Schnoll, R. A. (2019). Differences in the rate of nicotine metabolism among smokers with and without HIV. AIDS, 33(6), 1083–1088.
   PubMed Web of Science ®Google Scholar
• Ashare, R. L., Thompson, M., Serrano, K., Leone, F., Metzger, D., Frank, I., … Schnoll, R. A. (2019). Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV. Drug and Alcohol Dependence, 200, 26–33.
   PubMed Web of Science ®Google Scholar
• Aubin, H. J. (2009). Management of emergent psychiatric symptoms during smoking cessation. Current Medical Research and Opinion, 25(2), 519–525.
   PubMed Web of Science ®Google Scholar
• Benowitz, N. L., Jacob, P., III., Ahijevych, K., Jarvis, M. J., Hall, S., & LeHouezec, J. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4(2), 149–159.
   PubMedGoogle Scholar
• Brown, R. A., Burgess, E. S., Sales, S. D., Whiteley, J. A., Evans, D. M., & Miller, I. W. (1998). Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors, 12(2), 101–112.
   Web of Science ®Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12(3), 255–266.
   PubMed Web of Science ®Google Scholar
• Crawford, G., Weisbrot, J., Bastian, J., Flitter, A., Jao, N. C., Carroll, A., … Schnoll, R. (2019). Predictors of varenicline adherence among cancer patients treated for nicotine dependence and its association with smoking cessation. Nicotine & Tobacco Research. Advance online publication. doi: 10.1093/ntr/nty133
   PubMed Web of Science ®Google Scholar
• Drovandi, A. D., Chen, C. C., & Glass, B. D. (2016). Adverse effects cause varenicline discontinuation: A meta-analysis. Current Drug Safety, 11, 78–85.
   PubMed Web of Science ®Google Scholar
• Fiore, M., Jaén, C. R., Baker, T. B., Bailey, W. C., Benoqitz, N. L., Curry, S. J., … Leitzke, C. (2008). Treating tobacco use and dependence: 2008 update U.S. public health service clinical practice guideline executive summary. Respiratory Care, 53(9), 1217–1222.
   PubMed Web of Science ®Google Scholar
• Gross, R., Yip, B., Lo Re, V., III., Wood, E., Alexander, C. S., Harrigan, P. R., … Hogg, R. S. (2006). A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. The Journal of Infectious Diseases, 194(8), 1108–1114.
   PubMed Web of Science ®Google Scholar
• Grossberg, R., Zhang, Y., & Gross, R. (2004). A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57(10), 1107–1110.
   PubMed Web of Science ®Google Scholar
• Helleberg, M., Afzal, S., Kronborg, G., Larsen, C. S., Pederson, G., Pederson, C., … Obel, N. (2012). Mortality attributable to smoking among HIV-1-infected individuals: A nationwide, population-based cohort study. Clinical Infectious Diseases, 56(5), 727–734.
   PubMed Web of Science ®Google Scholar
• Holmes, W. C., & Shea, J. A. (1998). A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Medical Care, 36(2), 138–154.
   PubMed Web of Science ®Google Scholar
• Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5(1), 13–26.
   PubMed Web of Science ®Google Scholar
• Jarlenski, M., Baik, S. H., & Zhang, Y. (2016). Trends in use of medications for smoking cessation in medicare, 2007–2012. American Journal of Preventive Medicine, 51(3), 301–308.
   PubMed Web of Science ®Google Scholar
• King, D., Grasso, C., Dant, L., Elsesser, S. A., Crane, H. M., Cropsey, K. L., … O’Cleirigh, C. (2018). Treatment outcomes associated with quitting cigarettes among sexual minority men living with HIV: Antiretroviral adherence, engagement in care, and sustained HIV RNA suppression. AIDS and Behavior, 22(9), 2868–2876.
   PubMed Web of Science ®Google Scholar
• King, R. M., Vidrine, D. J., Danysh, H. E., Feltcher, F. E., McCurdy, S., Arduino, R. C., & Gritz, E. R. (2012). Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care and STDs, 26(8), 479–485.
   PubMed Web of Science ®Google Scholar
• Lerman, C., Schnoll, R. A., Hawk, L. W., Cinciripini, P., George, T. P., Wileyto, E. P., … PGRN-PNAT Research Group. (2015). Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: A randomised, double-blind placebo-controlled trial. The Lancet Respiratory Medicine, 3(2), 131–138.
   PubMed Web of Science ®Google Scholar
• Mdodo, R., Frazier, E. L., Dube, S. R., Mattson, C. L., Sutton, M. Y., Brooks, J. T., & Skarbinski, J. (2015). Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: Cross-sectional surveys. Annals of Internal Medicine, 162(5), 335–344.
   PubMed Web of Science ®Google Scholar
• Moreno, J. L., Catley, D., Lee, H. S., & Goggin, K. (2015). The relationship between ART adherence and smoking status among HIV+ individuals. AIDS and Behavior, 19(4), 619–625.
   PubMed Web of Science ®Google Scholar
• Nahvi, S., & Cooperman, N. A. (2009). Review: The need for smoking cessation among HIV-positive smokers. AIDS Education and Prevention, 21(Suppl. 3), 14–27.
   PubMed Web of Science ®Google Scholar
• Norris, T., Schiller, J. S., & Clarke, T. C. (2018). Early release of selected estimates based on data from the national health interview survey. Retrieved from https://www.cdc.gov/nchs/nhis/releases.htm
   Google Scholar
• Pacek, L. R., Rass, O., & Johnson, M. W. (2017). Positive smoking cessation-related interactions with HIV care providers increase the likelihood of interest in cessation among HIV-positive cigarette smokers. AIDS Care, 29(10), 1309–1314.
   PubMed Web of Science ®Google Scholar
• Petoumenos, K., & Law, M. G. (2016). Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons. Current Opinion in HIV and AIDS, 11(5), 514–520.
   PubMed Web of Science ®Google Scholar
• Raposeiras-Roubin, S., Abu-Assi, E., & Iniguez-Romo, A. (2017). Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV. Current Opinion in HIV and AIDS, 12(6), 523–527.
   PubMed Web of Science ®Google Scholar
• Reddy, K. P., Parker, R. A., Losina, E., Baggett, T. P., Paltiel, A. D., Rigotti, N. A., … Walensky, R. P. (2016). Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: A US-based modeling study. Journal of Infectious Diseases, 214(11), 1672–1681.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Cano, R., Paulus, D. J., Zvolensky, M. J., López-Durán, A., Martínez-Vispo, C., & Becoña, E. (2018). Depressive symptoms in the trajectory of craving during smoking cessation treatment: A latent growth curve model. The American Journal of Drug and Alcohol Abuse, 44(4), 472–479.
   PubMed Web of Science ®Google Scholar
• Schnoll, R. A., Goelz, P. M., Veluz-Wilkins, A., Blazekovic, S., Powers, L., Leone, F. T., … Hitsman, B. (2015). Long-term nicotine replacement therapy: A randomized clinical trial. JAMA Internal Medicine, 175(4), 504–511.
   PubMed Web of Science ®Google Scholar
• Schnoll, R. A., Patterson, F., Wileyto, E. P., Heitjan, D. F., Shields, A. E., Asch, D. A., & Lerman, C. (2010). Effectiveness of extended-duration transdermal nicotine therapy: A randomized trial. Annals of Internal Medicine, 152(3), 144–151.
   PubMed Web of Science ®Google Scholar
• Shahab, L., Andrew, S., & West, R. (2014). Changes in prevalence of depression and anxiety following smoking cessation: Results from an international cohort study (ATTEMPT). Psychological Medicine, 44(1), 127–141.
   PubMed Web of Science ®Google Scholar
• Shuter, J., Salmo, L. N., Shuter, A. D., Nivasch, E. C., Fazzari, M., & Moadel, A. B. (2012). Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: A national survey. AIDS and Behavior, 16(2), 288–294.
   PubMed Web of Science ®Google Scholar
• Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S. (2017). Depression and smoking cessation: Evidence from a smoking cessation clinic with 1-year follow-up. Annals of Behavioral Medicine, 51(3), 454–463.
   PubMed Web of Science ®Google Scholar
• Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014). Change in mental health after smoking cessation: Systematic review and meta-analysis. BMJ, 348, g1151–g1151.
   PubMed Web of Science ®Google Scholar
• Wandeler, G., Johnson, L. F., & Egger, M. (2016). Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: Comparisons with general population. Current Opinion in HIV and AIDS, 11(5), 492–500.
   PubMed Web of Science ®Google Scholar
• Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.
   PubMed Web of Science ®Google Scholar